过敏性鼻炎患者的甲状腺素水平增加
Violeta Lokaj-Berisha1, Besa Gacaferri Lumezi2
1Department of Physiology and Immunology, Faculty of Medicine, University of Prishtina "Hasan Prishtina", Bulevardi I Deshmoreve P.N., Prishtina, Kosovo.
Scientific reports
|January 21, 2025
概括
甲状腺功能变化和免疫球蛋白E (IgE) 升高与过敏性鼻炎和喘等呼吸道过敏有关. 这些发现表明了管理这些常见疾病的新治疗目标.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性鼻炎和喘是普遍存在的多因素起源的呼吸道疾病.
- 甲状腺功能对这些过敏性疾病的影响还不太清楚.
- 了解这些联系对于开发有效治疗方法至关重要.
研究的目的:
- 研究甲状腺激素水平与过敏呼吸道疾病之间的关系.
- 评估血清免疫球蛋白E (IgE) 与过敏个体甲状腺功能之间的相关性.
- 探索这些关联中的潜在的性别特异差异.
主要方法:
- 研究了一组116名参与者 (66名过敏性鼻炎,20名喘患者,30名对照患者).
- 测量包括身体质量指数 (BMI),血清IgE,T3,T4和甲状腺刺激激素 (TSH) 水平.
- 使用统计分析,包括皮尔森相关性,以确定有意义的关联.
主要成果:
- 与对照组相比,患有呼吸道过敏的患者的血清IgE水平显著更高.
- 在过敏性鼻炎患者中观察到血清T4水平的显著差异.
- 皮尔森相关性揭示了年龄,BMI和甲状腺激素之间的关联,显着的性别特异性差异.
结论:
- 这项研究表明,在呼吸道过敏中,代谢,内分泌和免疫系统之间存在复杂的相互作用.
- 升高的IgE和改变的甲状腺功能,特别是在男性中,可能提供新的治疗干预点.
- 进一步的研究是有必要的,以充分理解这些观察到的关系背后的机制.
相关概念视频
01:20Synthesis and Regulation of Thyroid Hormones
4.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.3K
02:06Allergic Reactions
27.3K
Overview
27.3K
01:27Allergic Drug Reactions
821
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
821
01:17Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:19Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253